These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22509878)

  • 1. Prothrombinex-VF use in warfarin reversal and other indications.
    Kruger PC; Le Viellez AS; Herrmann RP
    Med J Aust; 2012 Apr; 196(7):462-5. PubMed ID: 22509878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.
    Bobbitt L; Merriman E; Raynes J; Henderson R; Blacklock H; Chunilal S
    Thromb Res; 2011 Dec; 128(6):577-82. PubMed ID: 21621251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update of consensus guidelines for warfarin reversal.
    Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
    Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation.
    Tran H; Collecutt M; Whitehead S; Salem HH
    Intern Med J; 2011 Apr; 41(4):337-43. PubMed ID: 20403070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin reversal: an audit of prescribing practices at Capital and Coast District Health Board.
    Jolliffe E; Flanagan P
    N Z Med J; 2014 Sep; 127(1403):32-40. PubMed ID: 25290497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective review of Prothrombinex use by SAAS MedSTAR.
    Fischer R; Brettig S; Pearce A
    Emerg Med Australas; 2017 Apr; 29(2):178-183. PubMed ID: 27875857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correct dosing of Prothrombinex-VF in normalising elevated international normalised ratio in critically ill patients: a prospective cohort pilot study.
    McAlister AC; Ho KM
    Intern Med J; 2023 Sep; 53(9):1654-1669. PubMed ID: 36330546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy.
    Htet NN; Barounis D; Knight C; Umunna BP; Hormese M; Lovell E
    Am J Emerg Med; 2020 Mar; 38(3):539-544. PubMed ID: 31176578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombinex®-VF in chronic liver disease: Friend or foe?
    Latona A; Hill K; Connelly A; Stuart K; Wood P
    Emerg Med Australas; 2023 Feb; 35(1):89-96. PubMed ID: 35993256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal.
    Klein L; Peters J; Miner J; Gorlin J
    Am J Emerg Med; 2015 Sep; 33(9):1213-8. PubMed ID: 26143315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed?
    Crawford JH; Augustson BM
    Med J Aust; 2006 Apr; 184(7):365-6. PubMed ID: 16584376
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.
    Goldstein JN; Thomas SH; Frontiero V; Joseph A; Engel C; Snider R; Smith EE; Greenberg SM; Rosand J
    Stroke; 2006 Jan; 37(1):151-5. PubMed ID: 16306465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
    Huynh TK; Costello JL; Rebuck JA
    Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy.
    Kalina M; Tinkoff G; Gbadebo A; Veneri P; Fulda G
    Am Surg; 2008 Sep; 74(9):858-61. PubMed ID: 18807678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose 3-factor prothrombin complex concentrate for warfarin reversal prior to heart transplant.
    Kantorovich A; Fink JM; Militello MA; Wanek MR; Smedira NG; Soltesz EG; Moazami N
    Ann Pharmacother; 2015 Aug; 49(8):876-82. PubMed ID: 25986007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.